Home » Teva May Raise Forecast After Provigil Decision, Analyst Says
Teva May Raise Forecast After Provigil Decision, Analyst Says
Teva Pharmaceutical may raise its earnings forecast when it reports results next month to reflect the U.S. Food and Drug Administration’s decision on the narcolepsy drug Provigil, an analyst said.
Bloomberg
Bloomberg
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May